adrs (vk)
TRANSCRIPT
ADVERSE DRUG REACTIONS
DEFINATIONS
Adverse drug reactions (WHO):
Any response to a drug that is noxious and unintended
and that occurs at doses used in man for prophylaxis,
diagnosis or therapy of disease or modification of
physiological states.
All Drugs are Dangerous
No Drugs are Dangerous if used properly
How dangerous a drug is depends on the skill of the prescriber
The most dangerous drugs have the greatest potential for benefit
Some drugs are dangerous in acute poisoning but not when used therapeutically
Some drugs have a low therapeutic ratio
Some drugs have a low incidence of horrendous effects
Some adverse effects can be predicted if you know the pharmacology (Type A); some are not (Type B)
Some adverse effects occur after a delay or after stopping
BADGOOD
RISK BENEFIT
When prescribing drugs a doctor must assess risk to benefit ratio in the individual patient by
•Choosing an appropriate class of drug then an appropriate individual agent
•Is it effective ?
•What are the chances of adverse effect ?
•Are there features in this patient which affect choice eg other drugs, organ failure, aged
•Tailoring the dose
•Considering duration of treatment
The Risk to Benefit Ratio
Epidemiology
4% of hospital admissions1 in 1000 deaths in medical wards10 to 20 % of in-patients5% of patients in general practice
More frequent in elderly:erratic drug takingmultiple pathologyaltered pharmacokineticsincreased sensitivity of CNS
and CVS
Drugs - anti-coagulants, NSAIDs,corticosteroids, anti-hypertensives, anti-biotics, diuretics and insulin.
Occur in circumstances related to drug’s pharmacology, predisposing factors in the patient and care taken in choosing the drug and the dose.
SIDE EFFECTS-Pharmacological effects produced with therapeutic dose of drug.Troublesome in one condition but useful in others.Ex. atropine
UNTOWARD EFFECTS-Undesirable effects with therapeutic dose of the drug ,if severe requires
caessation of treatment.Ex.tetracyclines,aspirin
TOXIC EFFECTS-Effects produced by large & / repeated dosesEx. morphine
TYPES ADR
QUANTITATIVE QUALITATIVE(Type A) (Type B)
IDIOSYNCRASY ALLERGY Genetic Unknown I II III
IV (HYPERSENSITIVITY)
Comparison –type A &BType A Type B
1.Nature
2.Mechanism
3. Predictable
4.Incidence
5.Mortality
6. Treatment
7.Dose dependent
augmented/ attenuated normal
Hyper/ hypo response
Yes
high
Low
Adjust dose
Yes
Totally abnormal, bizarre response
Genetic, immunological,UK
No
Low
High
Stop the drug
No
IDIOSYNCRASY
GENETIC• G6PD DEFECIENCY• ATYPICAL PSEUDOCHOLINESTRASES
UNKNOWNChloramphenicol –Aplastic anaemia
ALLERGIC REACTION
FEATURES1. Ranges from mild- severe (anaphylaxis)2. Prior sensitization requried3. Immunologically mediated4. Low incidence , unpredictable, dose
independent.
Hypersensitivity
Hypersensitivity is an immune reaction to innocuous antigens that results in tissue injury and/or diseaseAn antigen that causes allergy is an allergen
TYPES OF ALLERGIC REACTIONS
I.IgE MEDIATED REACTION AND ANAPHYLAXIS-(immediate hypersensitivity)
• Systemic anaphylaxis- ex.penicillin. Antigen + IgE antibodies—influx of ca++ ----degranulation of mast
cells ,basophiles—release of histamine---anaphylaxis• Local anaphylaxis -Hay fever -Asthma -Diarrhea, gi.Pain. -Skin rash
Allergy (type I hypersensitivity mediated by IgE on mast cells)
Mast cell degranulation by antigen (allergen) cross-linking of FceR-bound IgE
Mast cell activation has many effects
TYPE II ALLRGIC REACTIONCytotoxic type reaction- Antibodies binds to antigen present on the cell surface
promotes phagocytosis of cell or cell destruction by polymorphs, macrophages or by lymphoid killer cells.
Examples-Transfusion reactionsRh incompatibility• drugs-antigenic complex with blood cells----increase
humoral antibodies----cytotoxic – haemolysis / agranulocytosis / thrombocytopenia
Type II hypersensitivityType II hypersensitivity (IgG-mediated anti-
cell-associated antigen response) is rare
Immune response to certain drugs (e.g.,
penicillin) where drug binds to cell surface and
antibody cause removal of the cells (usually
by macrophages).
TYPE III
IMMUNE COMPLEX MEDIATED REACTIONS ANTIGEN+HUMORAL ANTIBODIES
IMMUNE COMPLEXES
Ab EXCESS Ag EXCESS
Ppt.NEAR SITE OF ENTRY DEPOSIT IN SKIN, JOINTS SKIN-ERYTHEMA,EDEMA, ETC. KIDNEY
ARTHUS REACTION SERUM SICKNESS
Arthus Reaction: acute antibody-mediated hypersensitivity to soluble
antigens
TYPE IV
CELL MEDIATED REACTION-(Delayed hypersensitivity) Inflammatory reaction initiated by T cells. Delayed-secondary cellular response occurs after 48
hrs of antigen exposure. Examples-1.montoux reaction-i.d. tuberculin inj.2.Sulphonamides
Four Types of Hypersensitivities
MANIFESTATION OF ADR
1. Haemopoetic toxicity2. Hepatotoxicity –direct / immunological3. Nephrotoxicity4. Abnormality in taste & smell5. Occular toxicity6. Ototoxicity7. Behavioural toxicity8. Iatrogenic diseases9.Teratogenicity
32
Risk Factors for Adverse Drug Reactions
Simultaneous use of several different drugs– Drug-drug interactions
Very young, or very old in agePregnancyBreast FeedingHereditary FactorsDisease states which may effect drug absorption, metabolism, and/or elimination
33
Risk Factors Examples: Simultaneous Drug Use or Drug-Drug Interactions
Cerivastatin-Gemfibrozil interactions in hypercholesterolemia patients (rhabdomyolysis)
Coumadin-NSAID interactions (increased inhibition of platelet aggregation)
Venlafaxine-indinavir interactions in depressed HIV-infected patients (decreased indinavir concentrations)
34
Risk Factors Examples: Age Related Issues
Children are often at risk because their capacity to metabolize drugs is usually not fully developed– Newborns cannot metabolize or eliminate chloramphenicol, an
antibiotic– Children younger than 18 may be at risk of developing Reye’s
syndrome if given acetylsalicylic acid (aspirin) while infected with chickenpox or influenza
– Central nervous system effects of topiramate in children (seizures, tremor, and dizziness)
35
Risk Factors Examples: Age Related Issues
ADRs, including drug interactions, are a common cause of admission to hospitals in the elderly
Reasons for ADRs in the elderly:– Concomitant use of several medications– Disease states leading to drug ADME changes– Decreased drug ADME activity due to age
These conditions are exacerbated by malnutrition and dehydration, common in the elderly
36
Risk Factors Examples: Pregnancy
Use of sulfonamides (antibiotic) can lead to jaundice and brain damage in the fetus
Warfarin use for anticoagulation can lead to birth defects, and increased risk of bleeding problems in newborns and mothers
Lithium, for bipolar disorder, can lead to defects of the heart, lethargy, reduced muscle tone, and underactivity of the thyroid gland
37
Risk Factors Examples: Breastfeeding
Similar concerns, as for other children with underdeveloped capability to metabolize or excrete xenobiotics
Many drugs can be passed from mother to infant via breast milk– Amantadine (antiviral)– Cyclophosphamide (antineoplastic)– Cocaine (Schedule 2 FDA drug)– Carisoprodol (skeletal muscle relaxant)
38
Risk Factors Examples: Hereditary Factors
Genetic polymorphisms may play a role– Evident in CYP2C9 and 2C19, especially in the Asian population
(phenytoin)– May lead to impaired metabolism in mutation of enzymes
Higher risk of hemolysis in some populations, such as African, Middle Eastern, and South East Asian races– Quinolones– Antimalarials
39
Risk Factors Examples: Disease States
Metabolism (Phase I or II) may be impaired with hepatic disease – Cirrhosis– Hepatic Carcinoma
Renal Insufficiency– Acute or Chronic Renal Failure– Decreased glomerular filtration rate (GFR)
Drug levels may become toxic if too high, so dosing modifications may be indicated